Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors
This study has been completed.
Study NCT00070096 Information provided by National Cancer Institute (NCI)
First Received: October 3, 2003 Last Updated: July 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Extragonadal Germ Cell Tumor
Ovarian Cancer
Testicular Germ Cell Tumor
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Neoplasms, Germ Cell and Embryonal
Nervous System Neoplasms
Ovarian Neoplasms
More general conditions related to this trial
Adnexal Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Nervous System Diseases
Ovarian Diseases
Urogenital Neoplasms
Interventions listed in this trial
ixabepilone
Additional drug interventions recognized in this trial
Epothilones
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
